AzTrials
AzTrials

Shoulder PainNCT04777578

Effects of Dry Needling in Teres Major in Patients With Shoulder Pain

A study testing Dry needling in people with Shoulder Pain, run by Universidad de Zaragoza at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to investigate the effects of the dry needling technique in teres major muscles on pain, range of motion, strength and extensibility of the posterior part of the tissues of the shoulder in athletes with shoulder pain. Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Shoulder Pain
What is being tested?
Dry needling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
25 Feb 2021to 5 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Athletes with Shoulder pain
  • Glenohumeral internal rotation deficit
  • Presence of active MTrP in the teres major muscle

Who cannot join

  • Previous surgery in the upper limb
  • Previous physiotherapy treatments in the shoulder
  • Dry needling contraindications
  • Previous dry needling experience to mantain the blinding

Trial locations and contacts

1 site in 1 country.

Luis Ceballos Laita, PhD contact

975 12 91 00 ext. 9196

luis.ceballos@uva.es

Luis Ceballos Laita contact

975 12 91 00

luis.ceballos@uva.es

Spain1 site, 1 recruiting
  • Luis Ceballos Laita

    Soria, 42004

    Luis Ceballos Laita, Ph.D, luis.ceballos@uva.es

    Recruiting

Other trials in Spain

About this study

The aim of the study is to investigate the effects of the dry needling technique in teres major muscles on pain, range of motion, strength and extensibility of the posterior part of the tissues of the shoulder in athletes with shoulder pain.

Conditions
Shoulder Pain
Being tested
Dry needling
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dry needlingOther

    Dry needling based on fast-in fast-out technique in the teresa major muscle

Study groups in NCT04777578
Study groupRoleWhat they receive
DNExperimentalNot described
Receives: Other: Dry needling
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    the examiners assess the pain intensity using a visual analoigue scale

    Measured: Baseline

  2. Pain intensity

    the examiners assess the pain intensity using a visual analoigue scale

    Measured: immediately after the intervention

Secondary outcomes (6)
  1. Range of motion

    the examiners assess the shoulder range of motion with an universal goniometer

    Measured: Baseline

  2. Range of motion

    the examiners assess the shoulder range of motion with an universal goniometer

    Measured: immediately after the intervention

  3. Strength

    the examiners assess the shoulder range of motion with a hand-held dynamometer

    Measured: Baseline

  4. Strength

    the examiners assess the shoulder range of motion with a hand-held dynamometer

    Measured: immediately after the intervention

  5. Extensibility

    the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer

    Measured: Baseline

  6. Extensibility

    the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer

    Measured: immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2021
  2. Study start25 Feb 2021
  3. Primary completion20 Dec 2021 (estimated)
  4. Study completion5 Jan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04777578
Sponsor's protocol ID
CASVE-NM-21-504
Status last verified
Mar 2021
First submitted
25 Feb 2021
Last updated
2 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Dry needling in people with Shoulder Pain, run by Universidad de Zaragoza at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Luis Ceballos Laita, PhD (975 12 91 00 ext. 9196, luis.ceballos@uva.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in